Consult Our Doctor On Video Call from Home.
Dial 040-44885000 Or Press Here to Book an Appointment

Centre For Blood Disorders

Myelodysplastic Syndrome Treatment Cost

What is Myelodysplastic Syndrome?

Myelodysplastic syndromes (MDS) are diseases that can develop when the bone marrow's blood-forming cells change. Low levels of one or more types of blood cells result from this. MDS is regarded as a form of cancer. The Myelodysplastic Syndrome Treatment cost in Hyderabad depends upon various factors. So you must contact the doctor to know about the MDS syndrome treatment price in Hyderabad.

But before knowing the Myelodysplastic Syndrome Treatment cost in Hyderabad there are other important things to know about. The main goals of myelodysplasia treatment in Hyderabad are to decrease the condition's progression, relieve symptoms, and avoid consequences. Blood transfusions and drugs to increase blood cell production are common preventative strategies. A bone marrow transplant sometimes referred to as a stem cell transplant may be suggested in some cases to replace your unhealthy bone marrow with healthy bone marrow from a donor. Stem cell transplant is the accepted treatment for Myelodysplastic Syndrome. Also known as a bone marrow transplant, this procedure involves administering doses of chemotherapy, radiation, or medicines to remove the defective cells and swap them out for healthy donor-provided (allogeneic) stem cells. Blood transfusions and medication therapy are two alternative forms of treatment.

Myelodysplastic Syndrome signs and symptoms

Myelodysplastic Syndrome often affects people over the age of 60. Although younger people can also experience it. It can range from mild to severe, depending on the individual. Early symptoms aren't always identified, and they are occasionally noticed through a regular blood test. These signs include:

  • Breathing difficulty

  • Infection

  • Paleness brought on by sickness

  • Bruising or unusual or effortless bleeding

  • Little reddish spots under the skin

  • Recurring illnesses

  • A bone ache

Myelodysplastic Syndrome Treatment

The Myelodysplastic Syndrome Treatment cost in Hyderabad varies from place to place. So before getting the treatment you must be aware of the MDS syndrome treatment price in Hyderabad. Patients with myelodysplastic syndromes might receive a variety of myelodysplasia treatment in Hyderabad. Clinical trials are being conducted to test various treatments, some of which are standard (currently used treatments). A clinical trial for treatment is a research project designed to find out more about potential new treatments for cancer patients or to assist enhance existing treatments. A new treatment might replace the standard one if clinical trials reveal that it is superior to the current one. Patients might consider participating in a clinical trial. Only patients who have not begun treatment are allowed to participate in some clinical trials.


  1. How long after a Stem cell transplantation surgery in Hyderabad should I stay in the hospital?

    Around one and three months after the transplant, many patients are healthy enough to be discharged. However, you might not be able to leave the hospital for as long if you experience complications like an infection.

  2. What is Stem cell transplantation surgery in Hyderabad?

    Before starting treatment, it is crucial to understand how much Myelodysplastic Syndrome Treatment cost in Hyderabad. KIMS will assemble a group of medical professionals from various specialities to treats patients holistically. These medical experts work together to develop a treatment plan for each patient.

  3. Does having a stem cell transplant hurt?

    You will receive a catheter that is provided under general anaesthetic throughout the Stem cell transplantation surgery in Hyderabad, so you won't experience any pain. Radiation or chemotherapy will be administered as part of a conditioning programme to get your body ready for a transplant. You could experience adverse effects from this surgery. The transplant is also administered while alert and is not incapacitating.



Footer Loading...